Angelo Dei Tos
机构: Director of Pathology
每年引用次数
引用次数
引用: 43,145
H-指数: 104
I10-指数 : 343
出版物: 808
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson , Jaap Verweij , Hans Gelderblom , Jörg T Hartmann
The Lancet Oncology 15 ( 4) 415 -423
536
2014
Well-differentiated liposarcoma (atypical lipomatous tumors).
A Furlanetto , E Orvieto , L Laurino , A P Dei Tos
Seminars in Diagnostic Pathology 18 ( 4) 258 -262
105
2001
Classification of pleomorphic sarcomas: where are we now?
A P Dei Tos
Histopathology 48 ( 1) 51 -62
104
2006
Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis.
A Righi , M Gambarotti , M Sbaraglia , T Frisoni
Clinical sarcoma research 5 ( 1) 15 -15
20
2015
[Liposarcoma: controversies and conceptual problems].
Dei Tos Ap
Pathologica 88 ( 6) 467
1996
[GIST: from diagnosis to molecular therapy].
Dei Tos Ap
Pathologica 95 ( 5) 251 -251
1
2003
Treatment of laryngeal adenoid cystic carcinoma
Serafini I , Lucioni M , Bittesini L , Della Libera D
Acta Otorhinolaryngologica Italica 11 ( 1) 13 -24
5
1991
[New diagnostic markers: podoplanin-d2-40].
Doglioni C , Dei Tos Ap , Chilosi M
Pathologica 97 ( 3) 158 -159
3
2005
[Malignant fibrous histiocytoma: an entity in the process of extinction?].
Dei Tos Ap
Pathologica 88 ( 6) 522 -524
1996
Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.
Dei Tos Ap , Orvieto E , Laurino L , Furlanetto A
Seminars in Diagnostic Pathology 18 ( 4) 267 -273
52
2001
The relevance of genetics and molecular pathology in mesenchymal tumours.
Doglioni C , Dei Tos Ap
Advances in clinical pathology : the official journal of Adriatic Society of Pathology 2 ( 3) 197 -204
1998
[Measurement of HER-2/neu in breast cancer: which methodologic approach?].
Dei Tos Ap , Orvieto E
Pathologica 93 ( 3) 183 -188
2001
[Role of HER-2 in the treatment of breast carcinoma].
Dei Tos Ap
Pathologica 95 ( 5) 278 -278
1
2003
Interobserver agreement in pleural effusion cytology
U Fedeli , L Fabbris , C Doglioni , A Fassina
Cytopathology 11 393 -393
2000
Liposarcoma: New entities and evolving concepts
A Dei Tos
Annals of Diagnostic Pathology 4 ( 4) 252 -266
248
2000
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies
J-Y Blay , M von Mehren , RL Jones , J Martin-Broto
ESMO open 8 ( 5) 101618 -101618
9
2023
Utility of CDX2 immunoreactivty in the diagnosis of metastatic adenocarcinoma to the liver
A Furlanetto , E Orvieto , L Laurino , A Dei Tos
LABORATORY INVESTIGATION 83 ( 1) 273A -273A
2
2003
Intermediate Malignant and Malignant Tumors of Soft Tissue Featuring a Spindle Cell Morphology
Marta Sbaraglia , A Dei Tos
A. Dei Tos (Author), Soft Tissue Sarcomas: A Pattern-Based Approach to Diagnosis 71 -218
1
2018
AIRTUM-Italia 2015: 3 milioni di italiani vivono dopo una diagnosi di tumore, ma incidenza e mortalità sono in calo
Luigino Dal Maso , Carlotta Buzzoni , Stefano Guzzinati , Emanuele Crocetti
EPIDEMIOLOGIA E PREVENZIONE 40 ( 1) 75 -75
1
2016
In the last 15 years, survival in Italian children (0-14 years) is increased to 12%. [Negli ultimi 15 anni la sopravvivenza per tumore nei bambini italiani di età 0-14 anni è aumentata del 12%]
M Fusco , A Trama , C Buzzoni , AIRTUM Working G roup Collaborators
Epidemiologia e prevenzione 38 62 -62
2014